Why did you decide to use it?
Hover to explore
Hover to explore
Hover to explore
After
The average upper eyelid lift with UPNEEQ in clinical studies was mm.
Sponsored Content by RVL Pharmaceuticals, Inc.
Finally, A Once-a-Day Treatment for Droopy Eyelids
Scroll to explore
W
Far from simply a cosmetic change, the onset of acquired ptosis can impact vision, affecting reading, working on a computer, and driving, among most other activities that require full vision. Cosmetically, most people affected with acquired ptosis must also endure the loss of eye symmetry, as eyelids rarely drop in unison. Remarkably, according to a study by Sridharan, et al., it is estimated that only 15% of people who have ptosis have received a diagnosis for the condition.
For someone like me with acquired ptosis, I call it a ‘cup of coffee’ for the lids... I looked like I had a few extra hours of sleep after just one drop.
Until recently, surgery was one of the few treatments for patients who wished to treat a drooping upper lid. UPNEEQ (oxymetazoline hydrochloride ophthalmic solution), 0.1%, the only FDA-approved prescription eyedrop for treating ptosis (low-lying lids) in adults, can lift the upper eyelid to open the eye. It’s a daily drop treatment that elevates the lid in as little as two hours.
The most common side effects from using UPNEEQ, occurring in 1-5% of patients, are eye inflammation, eye redness, dry-eye, blurred vision, eye pain at the time of use, eye irritation, and headaches. Click here to read full Important Safety Information.
Lorem ipsum dolor sit amet, consectetur
“I decided to use UPNEEQ because I’ve had right upper lid ptosis for the past five years,” says Thu. “It has made a difference in that I can [apply one drop] when I feel like I want to lose my droopy eye look.”
Hover to reveal
Lorem ipsum dolor sit amet, consectetur
“I don’t find myself straining to widen my eyes for photos,” adds Mark. “Plus, the bonus is no one has asked me if I am feeling sleepy or tired since I started using UPNEEQ drops. They’re simple, convenient, and take almost no time or effort to apply.”
A treatment therapy available as of September 2020, in clinical trials 84% of patients experienced some level of improvement in raising drooping eyelids after applying UPNEEQ. 74% of patients reported a greater than 50% improvement after using the eye drops. To apply UPNEEQ simply cut open the foil wrapper and remove the single-use vial. Apply one drop of UPNEEQ in each affected eye without touching the eye.
After
Before
Before
Many new challenges arise as we age, including a change in our appearance. Ptosis can also occur at any age. Until now, surgery was the primary avenue to treat ptosis, low-lying lids.
UPNEEQ provides a different path, a daily drop of fluid that raises our eyelids. Contact your eye care professional to see if UPNEEQ is right for you and ask about a trial sample. Visit the UPNEEQ website to learn more about this exciting development in treating ptosis in adults.
How did you hear about UPNEEQ?
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec imperdiet congue volutpat. Pellentesque pharetra eros purus, a mollis lacus placerat eu.
Why did you decide to use it?
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec imperdiet congue volutpat. Pellentesque pharetra eros purus, a mollis lacus placerat eu.
Has it made a difference for you, and how so?
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec imperdiet congue volutpat. Pellentesque pharetra eros purus, a mollis lacus placerat eu.
Would you recommend to others, and why?
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec imperdiet congue volutpat. Pellentesque pharetra eros purus, a mollis lacus placerat eu.
What is UPNEEQ?
IMPORTANT SAFETY INFORMATION
UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a prescription eyedrop used to treat low-lying lids (acquired blepharoptosis) in adults.
What warnings and precautions are associated with UPNEEQ?
EXPAND
What is UPNEEQ®?
IMPORTANT SAFETY INFORMATION
UPNEEQ (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a prescription eyedrop used to treat low-lying lids (acquired blepharoptosis) in adults.
What warnings and precautions are associated with UPNEEQ?
Low-lying lids may be related to conditions such as stroke and/or brain aneurysm, Horner syndrome, myasthenia gravis, loss of the ability to move eye muscles, eye infection and eye tumors. Ask your doctor if you have any of these conditions.
UPNEEQ is a type of medication that may affect your blood pressure. If you have heart disease, uncontrolled high or low blood pressure, or feel faint at rest or when quickly standing up, you should call your doctor if your symptoms get worse. Patients with reduced blood flow to the brain or heart, or patients who experience eye or mouth dryness due to an immune system disorder (Sjögren’s syndrome), should use care when taking UPNEEQ. Call your doctor immediately if you feel your symptoms may be getting worse.
UPNEEQ may increase the risk of eye pressure due to fluid buildup (angle-closure glaucoma) in patients with untreated narrow-angle glaucoma. Call your doctor immediately if you feel increased pressure in your eye after using UPNEEQ.
Do not let the tip of the UPNEEQ vial touch your eye or any other surface. This can help prevent eye injury or contamination. Each UPNEEQ vial is for one-time use and should be discarded after being used.
What are the most common side effects of UPNEEQ?
The most common adverse reactions with UPNEEQ (occurring in 1-5% of patients) were eye inflammation, eye redness, dry eye, blurred vision, eye pain at time of use, eye irritation, and headache.
What should my doctor know about before prescribing me UPNEEQ?
Your doctor should review your full medical history before prescribing UPNEEQ.
UPNEEQ belongs to a class of medication (alpha-adrenergic agonists) that may affect your blood
pressure. Use UPNEEQ carefully if you currently take an alpha-adrenergic antagonist medication to treat heart disease or an enlarged prostate. Patients taking beta-blockers, or other medications to treat hypertension or an abnormal heartbeat, should also be careful when using UPNEEQ.
Patients who use a certain class of antidepressant medication (monoamine oxidase inhibitors) should also be careful when using UPNEEQ, as it may affect the way your body absorbs the medication.
These are not all of the possible side effects of UPNEEQ. Tell your doctor if you have any side effect that bothers you or does not go away. Call your doctor for medical advice about side effects.
To report side effects or product complaints, contact RVL Pharmaceuticals at 1-877-482-3788. You may also report side effects to the FDA by calling 1-800-FDA-1088 or visit www.fda.gov/medwatch.
This document has summarized the most important safety information for UPNEEQ. For more in-depth safety information, please review the full Prescribing Information for UPNEEQ.
COLLAPSE
Low-lying lids may be related to conditions such as stroke and/or brain aneurysm, Horner syndrome, myasthenia gravis, loss of the ability to move eye muscles, eye infection and eye tumors. Tell your doctor if you have any of these conditions.
UPNEEQ is a type of medication that may affect your blood pressure. If you have heart disease, uncontrolled high or low blood pressure, or feel faint at rest or when quickly standing up, you should call your doctor if your symptoms get worse.
eyelids, also known as acquired ptosis. Though considered a reality of aging, acquired ptosis can affect adults at any age, though it is true that people over forty-five are the most affected age group.
e all accept that our looks will change as we age, yet some of these effects carry more consequences than others. Consider low-lying
“For someone like me with acquired ptosis, I call it a ‘cup of coffee’ for the lids,” says Mark, who learned about UPNEEQ from his optometrist after expressing his displeasure with his drooping eyelids. “I looked like I had a few extra hours of sleep after just one drop. When I use Upneeq, my eyelids don’t feel as heavy and I don’t have to use any conscious ‘effort’ or do active work to feel like I am keeping my eyes open.”
The once-a-day drop stimulates the muscle above the eye. An FDA-approved medication, UPNEEQ is available exclusively through RVL Pharmacy and is typically shipped directly to your home in just three days after getting a prescription from your doctor. A typical shipment contains 30 individual vials for daily application.
How did you hear about UPNEEQ?
It’s made a big difference
"
"
Did you know...
of people are aware and have sought a diagnosis for ptosis
15%
Slide to reveal
of patients reported a greater than 50% improvement
74%
muscle stimulation after using just one drop
24
of patients experienced some level of improvement
84%
e all accept that our looks will change as we age, yet some of these
effects carry more consequences than others. Consider low-lying eyelids, also known as acquired ptosis. Though considered a reality of aging, acquired ptosis can affect adults at any age, though it is true that people over forty-five are the most affected age group.
Click to explore
Click to explore
Click to explore
Click to explore
Click to explore
Click to explore
UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a prescription eyedrop
Click to reveal
UPNEEQ® is indicated for the treatment of acquired blepharoptosis in adults. Click here to read Important Safety Information
Until recently, surgery was one of the few treatments for patients who wished to treat a drooping upper lid. UPNEEQ (oxymetazoline hydrochloride ophthalmic solution), 0.1%, the only FDA-approved prescription eyedrop for treating ptosis (low-lying lids) in adults, can lift the upper eyelid to open the eye. It’s a daily drop treatment that elevates the lid in as little as two hours.
The most common side effects from using UPNEEQ, occurring in 1-5% of patients, are eye inflammation, eye redness, dry-eye, blurred vision, eye pain at the time of use, eye irritation, and headaches. Click here to read full Important Safety Information.
Not an actual patient.
Not an actual patient.
UPNEEQ® is indicated for the treatment of acquired blepharoptosis in adults. Click here to read Important Safety Information
®
An actual patient before and after Upneeq administration. The average upper eyelid lift with UPNEEQ in clinical studies was 1mm. This patient still exhibits asymmetry post dose.
An actual patient before and after Upneeq administration. The average upper eyelid lift with UPNEEQ in clinical studies was 1mm. This patient still exhibits asymmetry post dose.
"
"
Hover to reveal
1
"
"